Article
mbtD and celA1 association with ethambutol resistance in Mycobacterium tuberculosis: A multiomics analysis
31 Aug 2022
Abstract excerpt
Ethambutol (EMB) is a first-line antituberculosis drug currently being used clinically to treat tuberculosis. Mutations in the embCAB operon are responsible for EMB resistance. However, the discrepancies between genotypic and phenotypic EMB resistance have attracted much attention. We induced EMB resistance in Mycobacterium tuberculosis in vitro and used an integrated genome–methylome–transcriptome–proteome...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
